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Abstract
Recent progress in engineering the genomes of large animals has spurred increased interest in developing better animal
models for diseases where current options are inadequate. Here, we report the creation of Yucatan miniature pigs with
targeted disruptions of the low-density lipoprotein receptor (LDLR) gene in an effort to provide an improved large animal
model of familial hypercholesterolemia and atherosclerosis. Yucatan miniature pigs are well established as translational
research models because of similarities to humans in physiology, anatomy, genetics, and size. Using recombinant adeno-
associated virus-mediated gene targeting and somatic cell nuclear transfer, male and female LDLR+/2 pigs were generated.
Subsequent breeding of heterozygotes produced LDLR2/2 pigs. When fed a standard swine diet (low fat, no cholesterol),
LDLR+/2 pigs exhibited a moderate, but consistent increase in total and LDL cholesterol, while LDLR2/2 pigs had
considerably elevated levels. This severe hypercholesterolemia in homozygote animals resulted in atherosclerotic lesions in
the coronary arteries and abdominal aorta that resemble human atherosclerosis. These phenotypes were more severe and
developed over a shorter time when fed a diet containing natural sources of fat and cholesterol. LDLR-targeted Yucatan
miniature pigs offer several advantages over existing large animal models including size, consistency, availability, and
versatility. This new model of cardiovascular disease could be an important resource for developing and testing novel
detection and treatment strategies for coronary and aortic atherosclerosis and its complications.
Citation: Davis BT, Wang X-J, Rohret JA, Struzynski JT, Merricks EP, et al. (2014) Targeted Disruption of LDLR Causes Hypercholesterolemia and Atherosclerosis in
Yucatan Miniature Pigs. PLoS ONE 9(4): e93457. doi:10.1371/journal.pone.0093457
Editor: Yanqiao Zhang, Northeast Ohio Medical University, United States of America
Received February 6, 2014; Accepted March 5, 2014; Published April 1, 2014
Copyright:  2014 Davis et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by a grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health (HL102950). The funders had no
role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: BTD, XJW, JAR, JTS, FAR and CSR are employees of Exemplar Genetics, a company that has applied for a patent and intends to
commercialize the porcine models described. BTD, XJW, JAR, JTS, FAR and CSR are employees of Exemplar Genetics, a company that has applied for a patent and
intends to commercialize the porcine models described. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.
* E-mail: chris.rogers@exemplargenetics.com
. These authors contributed equally to this work.
Introduction
The application of gene targeting technology in livestock
animals, particularly pigs, has generated significant interest in
the development of new models of human diseases. In cases where
existing rodent models fail to recreate key clinical phenotypes, pigs
are an attractive alternative. Perhaps the best example of this is the
recent development of porcine models of cystic fibrosis (CF) [1,2].
Pigs expressing either null alleles or the common F508del
mutation in the cystic fibrosis transmembrane conductance
regulator (CFTR) gene closely recapitulate human CF, including
lung disease [3,4]. These models have been important in
elucidating new pathogenic mechanisms and uncovering previ-
ously unrecognized consequences of the disease; advances that
were not possible in prior models of CF [5,6]. Pigs also offer an
advantage when modeling diseases for which size is relevant to the
development of interventional devices and diagnostic equipment
for humans, such as atherosclerosis [7].
Atherosclerosis is characterized by the accumulation of prolif-
erative smooth muscle cells, macrophages, lipids, cholesterol,
calcium deposits, and cellular debris in vessel walls [8–10].
Atherosclerosis begins with the buildup of low-density lipoprotein
(LDL) in the subendothelial matrix [11]. This accumulation is
proportional to the levels of circulating LDL. These processes
result in plaque formation, arterial obstruction, and diminished
blood flow to organs. For unknown reasons, these plaques can
rupture, often when quite small, and lead to occlusive thrombosis,
resulting in myocardial infarction or stroke [12–14].
In humans, loss-of-function mutations in the LDL receptor
(LDLR) gene lead to familial hypercholesterolemia (FH) [15]. As its
name implies, FH is associated with elevated plasma concentra-
tions of total and LDL cholesterol. Approximately one in 500
people carries a mutation in one LDLR gene. These heterozygotes
typically have twice the normal plasma LDL levels and a
significantly increased risk for atherosclerosis. Individuals with
two defective LDLR alleles face early-onset atherosclerosis and
often die of the disease at a young age.
Several small and large animal models of hypercholesterolemia
and atherosclerosis are available today, but each has limited utility.
PLOS ONE | www.plosone.org 1 April 2014 | Volume 9 | Issue 4 | e93457
Murine models of atherosclerosis have been developed using
transgenic and gene targeting techniques [16–19]. While these
models have provided valuable insight into our current under-
standing of cardiovascular disease, differences between murine
atherosclerosis and the corresponding human disease have
hampered translation to the clinic [20]. For example, atheroscle-
rosis in mice develops above the aortic valve and progresses in an
antegrade fashion. Abdominal aortic atherosclerosis in humans
begins at the aortoiliac junction and progresses in a retrograde
fashion [21]. Also, mice typically do not develop coronary artery
atherosclerosis except in the most proximal regions, and these
lesions appear to be a direct extension of supra-aortic valve
atherosclerosis as opposed to developing separately in the coronary
arteries. In contrast, humans develop disease throughout the
coronary artery system. Another key limitation of the murine
models is size - the small size of the mouse limits their use in the
development of human devices (such as stents) and new imaging
technologies. Rabbit models of atherosclerosis have also been
studied extensively [22]. While they do present a more accurate
model of human atherosclerosis, like mice, their smaller size limits
their broad application.
Pigs have long been studied as models of human cardiovascular
disease, primarily due to similarities of their cardiovascular systems
and their more human-like size [23]. For this reason, the pig is a
preferred animal for testing in the cardiovascular device industry
[24,25]. Spontaneous atherosclerosis in pigs is rare, but when fed a
diet high in saturated fat and cholesterol, pigs can develop
advanced atherosclerotic lesions similar in type and location to
those seen in humans [26–29]. However, these diets are incredibly
expensive and require a long time to manifest disease, making
many studies cost-prohibitive.
Pigs with spontaneous hypercholesterolemia and FH have been
described by Rapacz and others [30–32]. These pigs harbor a
point mutation (R84C) in both LDLR alleles that reduces receptor
binding, as well as allele variations in ApoB that may further
contribute to the phenotype. Even when consuming a normal diet,
these pigs develop hypercholesterolemia and atherosclerotic
lesions ranging from fatty streaks to advanced plaques, with
accompanying calcification, neovascularization, hemorrhage, and
rupture [33]. Despite the promising phenotype, there are
significant drawbacks to the Rapacz FH pig. First, there is
substantial variability in the plasma cholesterol levels and disease
development [32]. This is likely due to the mild nature of the
mutation and the broad genetic background of these animals.
Second, the mutations were originally described in a large
domestic pig breed, with body weights in excess of 200 kg. Efforts
to downsize the pig by crossing with various miniature pig breeds
has resulted in smaller pigs, but has also led to greater phenotypic
variability [34].
Recently, the development of transgenic Yucatan miniature pigs
expressing a proprotein convertase subtilisin/kexin type 9 (PCSK9)
gain-of-function mutation (D374Y), which is associated with
human autosomal dominant FH, was reported [35]. These pigs
exhibit moderate hypercholesterolemia on standard pig feed, and
a more severe hypercholesterolemia and human-like atheroscle-
rosis following extended feeding of a high-fat, high cholesterol diet.
However, with the mutant transgene being permanently overex-
pressed at nearly 500 times the normal level (hepatic mRNA
expression), these pigs may have limited utility for treatments
designed to increase LDL receptor expression or reduce PCSK9
activity.
We endeavored to address the disadvantages of the current
models while maintaining the positive attributes of pigs in
accurately modeling human cardiovascular disease. We used gene
targeting and somatic cell nuclear transfer (SCNT) to create
Yucatan miniature pigs with targeted disruptions in one or both
LDLR alleles. We also evaluated the extent of hypercholesterol-




This study was carried out in accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health. The Institutional Animal Care
and Use Committee of Exemplar Genetics approved all animal
experiments. All animals were housed in Exemplar Genetics’
AAALAC-accredited facilities. Standard procedures for animal
husbandry were used throughout.
Fetal Fibroblast Isolation
Fetal fibroblasts were previously isolated from approximately
day 35 Yucatan miniature pig fetuses as previously described [36].
Fetus genders were identified by PCR amplification of the Y-
chromosome-specific Sry gene [37].
Cloning porcine LDLR genomic DNA
Genomic DNA was isolated from Yucatan fetal fibroblasts
(Qiagen). A 8.6 kb PCR product which included a region from
LDLR exon 2 to exon 6 was amplified using a high fidelity
polymerase (Platinum Taq High Fidelity; Invitrogen) and LDLR
primers 2F2 and 6R2 (see Table S1 for primer sequences). The
PCR product was subcloned into pCR2.1-TOPO (Invitrogen) and
sequenced. All DNA sequencing was performed by the University
of Iowa DNA Facility. This plasmid (referred to as pLDLR2/6)
served as the template for PCR amplification of the 59 and 39
homologous targeting arms.
Targeting Vector Construction
The 59 and 39 homology arms were amplified by PCR using
plasmid pLDLR2/6 and subcloned sequentially into a plasmid
containing a PGK-NeoR cassette. The primers for the 59 arm were
LDLR59armF (XhoI) and LDLR59armR (EcoRV). The primers for
the 39 arm were LDLR39armF (HindIII) and LDLR39armR
(HindIII). The engineered termination codon is at amino acid
position C128 (C128X). This targeting construct (pLDLR-Neo)
was used as a template to create the amplicon for the generation of
the LDLR-targeting proviral vector.
rAAV production
PCR amplification of a 4.5 kb amplicon from plasmid pLDLR-
Neo was achieved by using the following primers: AAV-LDLR-F
(NotI) and AAV-LDLR-R (NotI). This product was subcloned into
the rAAV proviral plasmid, pFBAAV2-CMVP.NpA (obtained
from University of Iowa Gene Transfer Vector Core) and grown
in Sure2 cells (Stratagene) to ensure ITR integrity. This proviral
plasmid is referred to as pAAV-LDLR-Neo. The rAAV targeting
virus was produced by the University of Iowa Gene Transfer
Vector Core.
Fetal fibroblast infection, selection, and screening
rAAV infection, antibiotic selection, and PCR screening (using
primers LDLR Ex4aF1 and LDLR Int4R1) were performed as
previously described [1]. The expected PCR screening product for
the wild-type allele was 1.5-kb and 3.2-kb product from the LDLR-
targeted allele.
LDLR-Targeted Pigs
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Southern blot
Genomic DNA isolation, whole genome amplification, and
Southern blotting procedures were performed as previously
described [1]. The DNA probes for LDLR and NeoR were
produced by PCR amplification using the following primers:
LDLR XmnI probe1F/LDLR XmnI probe 1R and PGK-NeoF/
NeoR-R, respectively.
Production of pigs by SCNT
Nuclear transfer was performed by Viagen, Inc. (Austin, TX) as
previously described [38]. Reconstructed oocytes were transferred
into synchronized post-pubertal gilts on the first day of standing
estrus. Following a midline incision to access the uterus,
reconstructed embryos were transferred into the oviduct at the
ampullary-isthmus junction. Recipient animals were checked for
pregnancy by abdominal ultrasound after day 21 and throughout
gestation.
Northern blot
Total RNA was isolated (RNaqueous-4 PCR; Ambion) from
LDLR+/+, LDLR+/2, and LDLR2/2 pig liver. Poly A+ RNA
was obtained from liver total RNA by using FastTrack MAG
mRNA Isolation Kits (Invitrogen). Northern blot analysis was
performed using the NorthernMax formaldehyde-based system
(Ambion). LDLR and GAPDH probe templates were amplified
Figure 1. LDLR-targeted pigs. A. Gene targeting strategy. Wild-type LDLR exons 2–6 are shown as gray boxes. NeoR cassette is depicted in red, with
the arrow showing the orientation relative to LDLR. The neomycin resistance cDNA is driven by a PGK promoter and flanked by loxP sites. The
engineered termination codon is indicated. Position of the LDLR Southern blot probe is shown, as are the XmnI restriction sites. B. LDLR+/2 piglets at
2 days of age. C. Southern blot of genomic DNA from LDLR+/2 cloned pigs. (Upper) XmnI digested genomic DNA was hybridized with a probe that
detects porcine LDLR downstream of the targeting vector boundary. The LDLR-targeted allele produced an approximately 7.8 kb band, and the wild-
type band is approximately 6.0 kb. (Lower) The same DNA was hybridized with a probe that detects the NeoR cassette, yielding only the targeted
7.8 kb band. Lanes 1–5 contain DNA from individual cloned LDLR+/2 pigs; lane 6 contains DNA from a wild-type pig. D. Sequence chromatogram of
the site of LDLR disruption by the NeoR cassette. The engineered termination codon is noted. E. Total cholesterol levels in plasma from 15–18 month
old LDLR+/2 pigs (n = 13) and wild-type controls (n = 7), *p,0.0001. Data presented with SD.
doi:10.1371/journal.pone.0093457.g001
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using the primer sets LDLR North8F/9R and pGAPDH
North1F/2R, respectively.
Reverse Transcription PCR
Total RNA was isolated as described above. First strand cDNA
was synthesized with 2 mg of total RNA using SuperScript III
(Invitrogen) and following manufacturer’s instructions. PCR was
performed using primers LDLR North4F and LDLR Exon 5R1,
which spans LDLR exons 1–5.
Western blot
Pig liver was homogenized on ice in RIPA buffer (1% NP-40,
1% Na-deoxycholate, 0.1% SDS, 0.15 M NaCl, 0.01 M NaPO4
pH 8.0, 2 mM EDTA) supplemented with protease inhibitor
cocktail (Sigma), 1 mM PMSF (Sigma), and 1 mM DTT. The
homogenate was centrifuged at 4uC, 10,0006g for 30 minutes,
and the supernatant was combined with SDS-PAGE sample buffer
(50 mM Tris-HCl pH 6.8, 2% SDS, 10% glycerol, 100 mM
DTT, 0.1% bromophenol blue). The liver lysate samples were
heated in boiling water for 5 minutes, cooled on ice, and sonicated
with a Sonic Dismembrator (Fisher Scientific). The samples were
electrophoresed in a 7.5% SDS-PAGE gel with Tris-Glycine
running buffer. Protein was transferred onto a PVDF Immobilon-
P Transfer Membrane (Millipore) using XCell II Blot Module
(Invitrogen) according to manufacturer’s instructions. Immunoblot
analysis was performed using primary antibodies against LDLR
(EP1553Y, Abcam), b–tubulin (SC-55529, Santa Cruz Biotech-
nology), and secondary antibodies conjugated with horseradish
peroxidase (SC-2317 and SC-2005, Santa Cruz Biotechnology).
Signal was detected using Chemiluminescent Detection Kit
(Pierce).
Lipid chemistry
Whole blood was collected in EDTA-containing tubes, and
plasma was prepared and frozen at 280uC. Lipid analysis of most
samples was performed by the Lipoprotein Analysis Laboratory in
the Department of Pathology at Wake Forest University School of
Medicine (Winston-Salem, NC). Total cholesterol was measured
by enzymatic assay, lipoproteins were measured by gel filtration
chromatography. Total cholesterol of samples from 15–18 month
old heterozygote animals was determined by LipoScience
(Raleigh, NC).
Atherosclerosis measurements and morphometric
analysis
The heart and coronary arteries from female LDLR+/+ and
LDLR2/2 littermates were flushed with normal saline and
perfusion-fixed under systemic pressure with 10% buffered
formalin. Abdominal aortas were immersion-fixed in 10%
buffered formalin. Sections of each coronary artery were taken
perpendicular to the direction of blood flow at one cm intervals
from their origin and embedded in paraffin. The number of
sections reflects the distance covered. In general there are an
average of 20 total coronary artery sections per pig heart: 7 left
anterior descending coronary artery, 10 right coronary artery, 3 to
4 circumflex. The coronary artery sections were stained with
Verhoeff-van Gieson to highlight the internal and external elastic
lamina. Adjacent sections were stained with hematoxylin and eosin
to confirm lesion details. The abdominal aorta between the renal
and iliac arteries was photographed for measuring the percent
surface area with raised lesions when macroscopically present as
follows: % surface area with raised lesions = (area with raised
lesions 4 total surface area) 6100. Measurements were confirmed
by Sudan IV staining. The abdominal aorta was then divided into
1 cm sized opened segments taken perpendicular to the direction
of blood flow from the level of the renal arteries to the origin of the
iliac arteries, producing on average 6 sections per pig and paraffin
embedded. Light microscopic sections were prepared from the
proximal half of each segment and stained with Verhoeff-van
Gieson and hematoxylin and eosin.
Statistics
Analysis for significance was performed with GraphPad Prism
software (GraphPad Software) using one-way ANOVA with post
hoc comparison using the Tukey test or unpaired Student’s t test,
as specified.
Results
Targeted disruption of porcine LDLR
Homologous recombination was used to disrupt the porcine
LDLR gene. Specifically, a neomycin-resistance cassette (NeoR) was
inserted into exon 4 of porcine LDLR (Figure 1A). Exon 4 encodes
a necessary portion of the LDL receptor’s ligand-binding domain
[39]. It is a frequent site of mutation in human FH and was also
targeted in a murine model, resulting in the loss of LDL receptor
function [17]. Additionally, a premature termination codon was
engineered immediately upstream of the NeoR insertion to ensure
that no functional protein was produced.
Recombinant adeno-associated virus (rAAV) was used to deliver
the targeting vector to male and female fibroblasts harvested from
Yucatan miniature pig fetuses. Following rAAV infection and
antibiotic selection, LDLR-targeted fibroblasts were identified
using PCR (Figure S1A). The gene targeting efficiency (1.8% in
male cells and 6.5% in female cells) was comparable to other
studies using rAAV to target porcine genes (Table 1) [1,40].
Several PCR-positive cell lines were further confirmed by
Southern blot analysis to contain the expected LDLR targeting
event and were free of random integration (Figure S1B).
Generation of LDLR+/2 pigs by SCNT
LDLR+/2 cells were used as nuclear donors for SCNT [38].
We performed 18 embryo transfers yielding 9 full term pregnan-
Table 1. Summary of LDLR gene targeting and SCNT activity.




litter Total Live Born
Male 1.8% 10 130 50% 4.8 24
Female 6.5% 8 122 50% 8.3 33
*Gene targeting efficiency reported as percentage of G418R clones that were properly targeted, as determined by PCR.
{Pregnancy rate refers to full-term gestation.
doi:10.1371/journal.pone.0093457.t001
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cies and 57 LDLR+/2 piglets (24 male and 33 female) (Figure 1B).
Southern blot and DNA sequencing confirmed the expected
genotypes (Figure 1C,D).
Naturally occurring FH pigs have previously been shown to
inherit the disease in a recessive manner with heterozygotes
displaying no significant elevation in total cholesterol [32]. To
assess whether this was true in LDLR-targeted Yucatan miniature
pigs, total cholesterol was measured in a group of 15 to 18 month
old male LDLR+/2 cloned pigs (n = 16) and wild-type controls
(n = 7) fed a standard diet (,2% fat and no cholesterol). LDLR+/2
pigs total cholesterol was elevated relative to control pigs (LDLR+/
+: 57.364.0 and LDLR+/2: 92.465.6, p,0.0001) (Figure 1E).
Figure 2. Molecular and biochemical characterization of LDLR+/+, LDLR+/2, and LDLR2/2 pigs. A. Genotyping by PCR. Expected sizes are
1.5 kb for wild-type LDLR and 3.2 kb for targeted LDLR. B. Southern blot of genomic DNA. (Left) XmnI digested genomic DNA was hybridized with a
probe that detects porcine LDLR downstream of the targeting vector boundary. The LDLR-targeted allele produced an approximately 7.8 kb band,
and the wild-type band is approximately 6.0 kb. (Right) The same DNA was hybridized with a probe that detects the NeoR cassette, yielding only the
targeted 7.8 kb band. C. Northern blot of LDLR and GAPDH mRNA. Full-length LDLR and GAPDH mRNAs are 5.1 and 1.5 kb, respectively. The asterisk
represents a minor mRNA species consisting of full-length LDLR mRNA plus the NeoR cassette. The bracket indicates two minor mRNA species that are
likely the result of nonsense-mediated mRNA altered splicing. D. Representative RT-PCR. Using PCR primers that amplify from exon 1 to exon 5, the
targeted LDLR allele produces no normal mRNA, but does produce mRNA species with deletions of exon 4 or exons 3 and 4. This is seen in both the
LDLR+/2 and LDLR2/2 pigs. This result was confirmed by DNA sequencing. E. Representative western blot of LDLR and b-tubulin. LDLR is ,150 kDa
and b-tubulin is 51 kDa.
doi:10.1371/journal.pone.0093457.g002
Table 2. Summary of lipid profiles from LDLR+/+, LDLR+/2, and LDLR2/2 pigs at birth and after 26 weeks on a standard diet.
Birth 26 weeks
LDLR+/+ (5) LDLR+/2 (21) LDLR2/2 (10) LDLR+/+ (5) LDLR+/2 (17) LDLR2/2 (7)
TC 64.267.0 88.3616.9* 490.8619.0** 67.066.6 98.363.1* 567.4634.3**
LDL-C 37.861.6 66.062.9* 451.2618.7** 31.663.7 62.962.9** 434.7626.7**
VLDL-C 4.860.7 4.360.3 30.762.2** 2.460.2 2.960.2 120.3610.5**
HDL-C 21.462.0 18.460.8 8.960.8** 33.263.0 32.661.0 12.461.2**
All values are presented with SD. Differences between LDLR+/+ and LDLR+/2 are significant where indicated, ANOVA: *p,0.05, **p,0.01. Differences between LDLR2/
2 and the other two genotypes are significant where indicated, ANOVA: *p,0.01.
doi:10.1371/journal.pone.0093457.t002
LDLR-Targeted Pigs
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Production of LDLR2/2 pigs by breeding
Cloned LDLR+/2 males and females were retained for
breeding purposes. For this study, sixteen litters were produced
and yielded the expected Mendelian inheritance of 20 LDLR+/+,
40 LDLR+/2, and 21 LDLR2/2 pigs. Since the sires and dams
were each derived via SCNT from single, LDLR-targeting events,
each litter produced from these matings is essentially from the
same cross.
Figure 2A,B shows representative genotyping results via PCR
and Southern blot. As mentioned previously, we disrupted exon 4
with a NeoR cassette and inserted a premature termination codon.
The most likely consequence of this mutation is the induction of
nonsense-mediated mRNA decay [41]. However, should a protein
be translated, it would be truncated in the ligand-binding domain,
lack the transmembrane-spanning segment, and be non-functional
[17]. An additional possibility could be the skipping of exon 4 via
nonsense-associated altered splicing [42]. This, too, would result in
a protein with no ability to bind LDL. Northern blot analysis of
liver mRNA suggests that the targeted allele produces no normal
LDLR transcripts (Figure 2C), and RT-PCR reveals the presence
of truncated mRNAs resulting from transcripts lacking exon 4 as
well as exons 3 and 4 (Figure 2D), each a scenario which should
result in a frameshift mutation. DNA sequencing confirmed these
results (data not shown). Finally, we evaluated all three genotypes
for the presence of LDL receptor protein in the liver, which is the
primary site of LDLR expression. Western blots confirmed that
Figure 3. Abdominal aortic and coronary atherosclerosis in a 26-week-old LDLR2/2 pig fed a standard diet. Measurements of percent
surface area with raised lesion in the abdominal aorta were taken from en face photographs of the abdominal aorta and confirmed by Sudan IV
staining (A). Aortic sections (rectangle) were stained with VVG and H&E (B,C), higher magnifications of atherosclerotic lesion (squares) are seen in D
and E. A representative section (with corresponding higher magnification) from the circumflex artery showing atherosclerotic plaque that appears to
have foam cells. (F,G–H&E H,I – VVG).
doi:10.1371/journal.pone.0093457.g003
Table 3. Summary of total cholesterol from LDLR+/+, LDLR+/
2, and LDLR2/2 pigs fed a high fat, high cholesterol diet for
90 and 180 days.
LDLR+/+ LDLR+/2 LDLR2/2
0 days 78.668.6 (11) 105.3618.6* (18) 619.1681.7** (17)
90 days 174.4638.2 (7) 250.2675.6* (10) 834.06117** (12)
180 days161.0623.6 (3) 323.8692.3** (5) 960.4646.9** (5)
All values are presented with SD. Differences between LDLR+/+ and LDLR+/2
are significant where indicated, ANOVA: *p,0.05, **p,0.01. Differences
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LDLR2/2 pigs produce no normal LDL receptor protein
(Figure 2E).
Lipid chemistry analysis
Plasma cholesterol levels were measured in LDLR+/+, LDLR+/
2, and LDLR2/2 piglets immediately at birth, before piglets
could suckle. This allows an initial assessment before lipid levels
are affected by the sow’s cholesterol- and fat-rich colostrum and
milk. As expected, cholesterol levels were significantly higher in
LDLR-targeted pigs than in their wild-type littermates. LDLR+/2
piglets exhibited a moderate, but statistically significant total
cholesterol elevation (similar to what was seen in LDLR+/2 male
clones described above), while LDLR2/2 pigs had dramatically
elevated levels (Table 2). A similar elevation is seen in LDL and
very low-density lipoprotein (VLDL). High-density lipoprotein
(HDL) was decreased in LDLR2/2 pigs, though not in LDLR+/2
pigs.
Cholesterol levels in pigs can vary widely while nursing (data not
shown). At three to four weeks of age, pigs were weaned and
placed on a standard diet consisting of no cholesterol and ,2%
fat. When measured again at 26 weeks of age, the cholesterol levels
in these pigs were similar to what was seen pre-suckle. These
cholesterol data are summarized in Table 2.
Early atherosclerosis in LDLR2/2 pigs
It is well established that elevated total and LDL cholesterol due
to dietary manipulation will lead to the development of
atherosclerosis in wild-type pigs. We asked whether LDLR2/2
pigs would show the presence of atherosclerosis having been fed a
standard pig diet with no added cholesterol or fat. We necropsied
three LDLR2/2 pigs and two LDLR+/+ controls at 7 months of
age and assessed the presence of atherosclerosis in the coronary
arteries and the abdominal aorta. The LDLR+/+ pigs had no
visible atherosclerosis in the abdominal aorta, while the LDLR2/
Figure 4. Abdominal aortic atherosclerosis in 11-month-old LDLR2/2, LDLR +/2, and LDLR +/+ pigs fed a high fat, high cholesterol
diet. Measurements of percent surface area with raised lesion in the abdominal aorta were taken from en face photographs of the abdominal aorta
and confirmed by Sudan IV staining (A,D,G). Aortic sections (rectangles) were stained with H&E (B, E, H) and higher magnifications of atherosclerotic
lesion (squares) are seen in C, F, and I. Representative sections from each are shown: LDLR2/2 (A,B,C), LDLR +/2 (D,E,F), and LDLR +/+ (G,H,I).
Atherosclerotic plaques from all the LDLR2/2 pigs had cholesterol clefts and some lesions also exhibited calcification as shown in B and C.
doi:10.1371/journal.pone.0093457.g004
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2 pigs had 45% of the abdominal aorta covered with raised
atherosclerotic lesions that were distributed fairly equally over
proximal and distal portions. Atherosclerotic lesions had areas of
probable foam cells and small areas of necrosis, hallmarks of
human atherosclerosis (Figure 3A–E).
Coronary arteries from the LDLR+/+ and LDLR2/2 pigs were
sectioned and stained with hemotoxylin and eosin (H&E) and
Verhoeff-van Gieson (VVG) and evaluated for the presence of
atherosclerosis. The LDLR+/+ pigs had no visible atherosclerotic
lesions in the right coronary artery (RCA), left anterior descending
artery (LAD), or circumflex artery (CIRC). Small areas of intimal
thickening were seen in the proximal portion of each. The
LDLR2/2 pigs however, had small atherosclerotic lesions, as well
as intimal thickening in sections from the RCA, LAD, and CIRC.
These were predominantly in the proximal portion of the arteries
but there was some extension into the distal portions as well. A
representative lesion is shown in Figure 3F–I. Lesions in the
coronary arteries appear to have foam cells, a hallmark of human
atherosclerosis.
High fat, high cholesterol diet accelerates atherosclerosis
We next sought to increase the severity and accelerate the onset
of atherosclerosis in the LDLR-targeted pigs by feeding a high fat,
high cholesterol diet. For this study, we included only females and
barrows (castrated males) since they are commonly used for
atherosclerosis studies in industry settings. All pigs were raised on a
standard diet until the age of 5 months, at which time they were
transitioned to a diet containing ,40% saturated fat and ,1%
cholesterol from natural sources including eggs and butter.
Cholesterol levels were measured following 90 and 180 days on
the diet (Table 3). There was no difference in total cholesterol
between females and barrows, so they have been combined within
each genotype for this study. After 90 days of ingesting the high
fat, high cholesterol diet, all three genotypes experienced
significant increases in total cholesterol, which continued to
increase at the 180-day time point.
The LDLR2/2 pigs had an appreciable amount of atheroscle-
rosis in the abdominal aorta. While the total abdominal aortic
surface area was comparable in all three groups, LDLR2/2 pigs
had significantly higher surface area with raised lesions and
percent aortic surface area covered with lesions (overall and in
both the proximal and distal portions) than either the LDLR+/2
or LDLR+/+ pigs (Figure 4, Table 4). By morphometric methods,
the intimal area and intimal area as percent of medial area were
also significantly larger (overall and in both the proximal and distal
portions) in the LDLR2/2 pigs than either the LDLR+/2 or
LDLR+/+ pigs (Table 4). All aortic atherosclerosis lesions from the
LDLR2/2 pigs had cholesterol clefts present and many had
calcification and apparent foam cells (Figure 4).
After 180 days of the high fat, high cholesterol diet, coronary
arteries from the 11-month old LDLR+/+, LDLR+/2, and
LDLR2/2 pigs were sectioned and stained with H&E and
VVG and evaluated for the presence of atherosclerosis. The
LDLR+/+ pigs had only minimal amounts of intimal thickening in
the RCA, LAD, and CIRC, while LDLR+/2 pigs had small areas
of atherosclerosis in addition to areas of intimal thickening. The
LDLR2/2 pigs however, had atherosclerotic lesions, as well as
intimal thickening in sections from the RCA, LAD, and CIRC.
Some lesions were complex with fibrous caps, hemorrhage,
calcification, and foam cells (Figure 5).
By morphometric methods, the coronary arteries from LDLR2/
2 pigs had overall significantly larger intimal area, percent
stenosis, and intimal area as percent medial area than the LDLR+/
+ or LDLR+/2 coronary arteries. This difference was predom-
inantly in the distal portion of the arteries with significantly larger
percent stenosis and intimal area as percent medial area in the
distal portion of coronary arteries from the LDLR2/2 pigs
(Table 5).
Discussion
We have produced new models of hypercholesterolemia and
coronary and aortic atherosclerosis in the commonly studied
Yucatan miniature pig breed by disrupting the endogenous LDLR
gene. LDLR+/2 pigs exhibit mild, yet consistent elevated
cholesterol that is present at birth and persists when fed a zero-
cholesterol, low fat diet. LDLR2/2 animals are born with severe
hypercholesterolemia and develop atherosclerotic lesions by 7
months of age. The phenotypes of the LDLR+/2 and LDLR2/2
pigs are accelerated when fed a high fat, high cholesterol diet.
Our results are consistent with human FH, a dominant disorder
exhibiting a gene dosage effect in which LDLR homozygotes
exhibit a more severe phenotype than LDLR heterozygotes.
Previous studies in Rapacz spontaneous hypercholesterolemic pigs
Table 4. Abdominal Aortic Atherosclerosis from 11-month
old LDLR+/+, LDLR+/2, and LDLR2/2 pigs fed a high fat, high
cholesterol diet.
LDLR +/+ (4) LDLR+/2 (6) LDLR2/2 (4)
En Face Measurements:
Abdominal Aorta
Total aortic surface area (cm2) 8.760.8 7.560.9 7.861.2
Area with raised lesion (cm2) 0.560.3 0.860.8 3.861.6**
% aortic surface with raised
lesions
5.864.4 10.168.8 48.5619.8**
Proximal Half Abdominal Aorta
Total aortic surface area (cm2) 4.360.4 3.860.4 3.960.6
Area with raised lesion (cm2) 0.260.2 0.360.4 1.660.6**
% aortic surface with raised
lesions
4.664.8 7.868.3 40.5614.5**
Distal Half Abdominal Aorta
Total aortic surface area (cm2) 4.460.4 3.760.5 3.960.6
Area with raised lesion (cm2) 0.360.2 0.560.4 2.261.1**





Medial area (mm2) 11.960.6 12.361.4 12.461.4
Intimal area (mm2) 0.260.1 0.360.2 4.462.1**
Intimal area as % medial area 1.961.0 2.761.7 35.4614.2**
Proximal Half Abdominal Aorta
Medial area (mm2) 11.460.4 11.961.1 12.861.9
Intimal area (mm2) 0.160.0 0.260.2 3.661.1**
Intimal area as % medial area 1.260.4 1.962.0 27.465.1**
Distal Half Abdominal Aorta
Medial area (mm2) 12.460.9 12.762.2 11.961.3
Intimal area (mm2) 0.460.2 0.560.2 5.463.2**
Intimal area as % medial area 2.761.7 3.661.7 43.8623.4**
All values are presented with SD. Differences between LDLR2/2 and the other
two genotypes are significant where indicated, ANOVA: **p,0.01.
doi:10.1371/journal.pone.0093457.t004
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(LDLR-R84C homozygotes) suggested that FH is a recessive disease
in pigs, because cholesterol levels in heterozygotes did not differ
from wild-type controls. However, this is likely due to the high
genetic variability seen in these animals, including the presence of
various ApoB alleles and other genetic modifiers [32]. The more
homogenous genetic background of the LDLR-targeted Yucatan
miniature pigs allows the difference between LDLR+/+ and
LDLR+/2 animals to be more readily observed.
LDLR-targeted Yucatan miniature pigs offer several advantages
over existing large animal models of hypercholesterolemia and
atherosclerosis. First, at 60–75 kg, mature Yucatan miniature pigs
are one-third to one-half the size of domestic pigs (including the
Rapacz FH pigs) making them more representative of average
human size and easier for most researchers to conduct studies.
This is important for studies directed at the development of new
human devices and diagnostic equipment. Second, due to the
‘‘knock-out’’ nature of the gene disruption, a more severe, and
thus more rapidly developing, atherosclerosis is possible in the
homozygotes compared to the Rapacz or PCSK9-D374Y
transgenic pigs. This will decrease the duration and costs of
studies. Furthermore, since the heterozygote pigs have only one
functional LDLR allele, they are susceptible to accelerated, diet-
induced hypercholesterolemia and atherosclerosis (compared to
wild-type animals). This makes them uniquely suited for the
development of therapeutic approaches that directly, or indirectly,
induce LDL receptor expression and the evaluation of a
treatment’s ability to impede or even reverse the progression of
atherosclerosis. This may not be possible with the constitutive
transgene expression in the PCSK9-D374Y pig. Finally, because
of the homogeneous genetic background of the miniature pig line,
the variability in phenotype and response to interventions seen in
current models should also be reduced.
This model also has some limitations, with perhaps the greatest
being its size and the challenges that come with it. A large animal
model requires specialized housing, trained staff, unique study
facilities, and in some cases, specially formulated diets. Most
current animal models of hypercholesterolemia and atherosclerosis
require a highly modified diet often consisting of 1–4% pure
cholesterol and sodium cholate, which are not typical of human
diets and with the latter being possibly toxic and counterproduc-
tive [43]. Furthermore, these diets are cost-prohibitive for many
researchers, with daily feed costs being ,40 times more expensive
than normal swine diets. We used a diet that is more representative
of human consumption containing natural sources of saturated fat
Figure 5. Coronary artery atherosclerosis in 11-month-old LDLR2/2, LDLR +/2, and LDLR +/+ pigs fed a high fat, high cholesterol
diet. Representative H&E stained sections from each group are shown: LDLR2/2 (A,B), LDLR +/2 (C,D), and LDLR +/+ (E,F). Complex lesions were seen
in the LDLR2/2 pigs (A,B) that exhibited hemorrhage, possible areas of calcification, fibrous caps and foam cells.
doi:10.1371/journal.pone.0093457.g005
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and cholesterol, which is significantly cheaper (2-3X normal swine
diets). A pig’s size is not ideal for early-stage drug development,
due to the amount of test compound required. Accordingly, pigs
may be better suited to bridge the large gap that exists between
small animal models and human clinical trials. For example,
several recent studies have shown promising results in the current
small animal models of atherosclerosis, only to fail in phase 3
studies [44]. If the porcine model were to offer more predictive
efficacy, the benefits would far outweigh the costs. Another
limitation is that pigs, like mice, lack cholesteryl ester transfer
protein (CETP). Inhibition of human CETP to increase circulating
HDL has been an area of intense study recently, however to date,
no drugs in this class have progressed beyond clinical trials [45].
Several issues regarding the LDLR-targeted Yucatan miniature
pigs remain to be addressed. We describe the presence of
advanced atherosclerotic lesions in eleven-month-old LDLR2/2
pigs fed a high fat, high cholesterol diet, but we did not observe
plaque rupture or thrombosis. A longer study is underway to better
establish the full spectrum and timeline of phenotypic develop-
ment, though the results presented here are encouraging. The
present study also does not address the impact of gender and
puberty on phenotype. Our standard diet study only looked at pigs
up to 6–7 months, which is the point at which pigs undergo
puberty. We saw no discernable differences between males and
females up to that point. The high fat, high cholesterol diet study
only looked at castrated males and females, and again, no
differences in atherosclerosis severity were seen. Finally, it is
obvious that an animal model with improved predictive efficacy is
needed. While that will take more time to demonstrate, we are
currently seeking to validate that drugs that have been successful in
humans are equally effective in the porcine model. Perhaps more
importantly, we would also like to know whether LDLR-targeted
pigs would have predicted the failure in humans of drugs that were
initially shown to be efficacious in mice.
The LDLR-targeted Yucatan miniature pigs provide a versatile
new model system for pursuing research into new devices,
diagnostic tools, and therapeutics for human cardiovascular
disease. This study further validates genetically engineered pigs
as useful biomedical models of human disease.
Supporting Information
Figure S1 Genotyping results from LDLR-targeted pig
fetal fibroblasts. A. Example of PCR results. Primers amplified
a 1.5 kb product from the wild-type allele and 3.2 kb product from
the LDLR-targeted allele. Lanes 1–5 are examples of PCR-positive
cell clones. Lane 6 is a wild-type cell clone. B. Southern blot of
whole genome amplified DNA. (Left) XmnI digested genomic DNA
was hybridized with a probe that detects porcine LDLR
downstream of the targeting vector boundary. The LDLR-targeted
allele produced an approximately 7.8 kb band, and the wild-type
band is approximately 6.0 kb. (Right) The same DNA was
hybridized with a probe that detects the NeoR cassette, yielding
only the targeted 7.8 kb band. Lane 3 is an example of a properly
targeted cell line. Lane 5 is a wild-type control.
(PDF)
Table S1 List of PCR and Sequencing Primers.
(PDF)
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